{
  "question_id": "XREF-008",
  "question": "How did the NeuroSync acquisition impact the NIM revenue trajectory?",
  "question_type": "cross-reference",
  "config": {
    "structure": "shallow",
    "model": "haiku",
    "loading_method": "classic",
    "load_percent": 100
  },
  "response": "{\"type\":\"result\",\"subtype\":\"success\",\"is_error\":false,\"duration_ms\":4665,\"duration_api_ms\":6056,\"num_turns\":1,\"result\":\"{\\n    \\\"answer\\\": \\\"The NeuroSync acquisition in 2020 dramatically accelerated NIM revenue, enabling the product line to grow from $712 million (9 months post-acquisition) to $5.8 billion by 2023, representing a 153% year-over-year growth in 2021 and a 133% growth in 2022. The acquisition brought critical neural interface technology, leading to FDA-approved medical applications and expanded market opportunities.\\\",\\n    \\\"confidence\\\": \\\"high\\\", \\n    \\\"sources_used\\\": [\\n        \\\"/history/acquisition-neurosync.md\\\", \\n        \\\"/products/nim-series.md\\\"\\n    ]\\n}\",\"session_id\":\"8b17706a-b3ca-473e-ab4a-54ad78a642e6\",\"total_cost_usd\":0.0626286,\"usage\":{\"input_tokens\":3,\"cache_creation_input_tokens\":60072,\"cache_read_input_tokens\":18990,\"output_tokens\":153,\"server_tool_use\":{\"web_search_requests\":0,\"web_fetch_requests\":0},\"service_tier\":\"standard\",\"cache_creation\":{\"ephemeral_1h_input_tokens\":60072,\"ephemeral_5m_input_tokens\":0}},\"modelUsage\":{\"claude-haiku-4-5-20251001\":{\"inputTokens\":123,\"outputTokens\":60,\"cacheReadInputTokens\":0,\"cacheCreationInputTokens\":0,\"webSearchRequests\":0,\"costUSD\":0.00042300000000000004,\"contextWindow\":200000,\"maxOutputTokens\":64000},\"claude-3-5-haiku-latest\":{\"inputTokens\":3,\"outputTokens\":153,\"cacheReadInputTokens\":18990,\"cacheCreationInputTokens\":60072,\"webSearchRequests\":0,\"costUSD\":0.0622056,\"contextWindow\":200000,\"maxOutputTokens\":8192}},\"permission_denials\":[],\"uuid\":\"44d19134-d9f8-4828-9135-97e251f17316\"}",
  "expected_answer": "NIM revenue grew from $712M in 9 months post-acquisition (2120) to $7.2B in 2124, representing rapid growth enabled by NeuroSync's technology",
  "metadata": {
    "duration_seconds": 6.835859518,
    "timestamp": "2026-01-29T20:13:45-07:00"
  }
}
